Sun Pharma.Inds.

Part of MojoOne Strategy

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE044A01036
NSEID: SUNPHARMA
BSEID: 524715

INR

1,745.00

-50.1 (-2.79%)

BSENSE

Dec 18

BSE+NSE Vol: 32.59 lacs

Click here to access the older version

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,745.00",
    "chg": -50.1,
    "chgp": "-2.79%",
    "dir": -1,
    "prev_price": "1,795.10",
    "mcapval": "421,359.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "32.59 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-hits-intraday-low-amid-price-pressure-3762668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_priceRelatedfactors_3762668.png",
        "date": "2025-12-18 11:39:41",
        "description": "Sun Pharmaceutical Industries experienced a notable decline today, touching an intraday low of Rs 1,738.8 as the stock faced downward pressure amid a mixed market environment. The pharmaceutical giant underperformed its sector and the broader market, reflecting immediate selling interest and cautious sentiment among investors."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Heavy Call Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-call-option-activity-amid-mixed-price-action-3762415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_most_active_stocks_calls_3762415.png",
        "date": "2025-12-18 10:00:13",
        "description": "Sun Pharmaceutical Industries has emerged as a focal point in the options market with significant call option trading activity observed ahead of the 30 December 2025 expiry. The pharmaceutical giant’s stock performance and option market dynamics suggest a notable positioning by investors anticipating potential price movements in the near term."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-put-option-activity-amid-bearish-sentiment-3762416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_most_active_stocks_puts_3762416.png",
        "date": "2025-12-18 10:00:13",
        "description": "Sun Pharmaceutical Industries Ltd has attracted significant attention in the options market, with put options seeing notable trading volumes and open interest as the 30 December 2025 expiry approaches. This activity reflects a cautious stance among investors amid recent price movements and sector dynamics."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3762107",
        "imagepath": "",
        "date": "2025-12-18 09:21:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are compelled to hold shares of Sun Pharma, thereby creating a steady demand irrespective of short-term market fluctuations.</p>\n                <p>Moreover, inclusion in the benchmark index often leads to increased scrutiny and expectations regarding corporate governance, financial transparency, and consistent performance. For Sun Pharmace..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Analytical Perspective Shift Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-3760860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3760860.png",
        "date": "2025-12-17 08:22:15",
        "description": "Sun Pharmaceutical Industries has experienced a revision in its market assessment, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article examines the factors influencing the recent analytical perspective shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3759775",
        "imagepath": "",
        "date": "2025-12-16 09:21:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.</p>\n                <p>Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-technical-momentum-shifts-amid-mixed-market-signals-3758316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_technicaldot_3758316.png",
        "date": "2025-12-15 08:04:43",
        "description": "Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory."
      },
      {
        "title": "Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-3757140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3757140.png",
        "date": "2025-12-12 08:11:55",
        "description": "Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Shows Mixed Technical Momentum Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-technical-momentum-shifts-to-bullish-amid-strong-buy-upgrade-3757077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_technicaldot_3757077.png",
        "date": "2025-12-12 08:08:57",
        "description": "Sun Pharmaceutical Industries has exhibited a nuanced shift in its technical momentum, reflecting a blend of bullish signals on shorter timeframes and more cautious indications over longer periods. The stock’s recent price movements and technical indicators suggest a complex market assessment, with investors weighing near-term optimism against broader market trends."
      }
    ],
    "total": 910,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 - Approval Of Proposal For Greenfield Project",
      "datetime": "02-Dec-2025",
      "details": "Intimation under Regulation 30 - Approval of proposal for Greenfield Project",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Dec-2025",
      "details": "Sun Pharma introduces Ilumya in India for the treatment of moderate-to-severe Plaque Psoriasis.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "26-Nov-2025",
      "details": "Press Release",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>550%</strong> dividend, ex-date: 07 Jul 25",
          "dt": "2025-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries Hits Intraday Low Amid Price Pressure

2025-12-18 11:39:41

Sun Pharmaceutical Industries experienced a notable decline today, touching an intraday low of Rs 1,738.8 as the stock faced downward pressure amid a mixed market environment. The pharmaceutical giant underperformed its sector and the broader market, reflecting immediate selling interest and cautious sentiment among investors.

Sun Pharmaceutical Industries Sees Heavy Call Option Activity Ahead of December Expiry

2025-12-18 10:00:13

Sun Pharmaceutical Industries has emerged as a focal point in the options market with significant call option trading activity observed ahead of the 30 December 2025 expiry. The pharmaceutical giant’s stock performance and option market dynamics suggest a notable positioning by investors anticipating potential price movements in the near term.

Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry

2025-12-18 10:00:13

Sun Pharmaceutical Industries Ltd has attracted significant attention in the options market, with put options seeing notable trading volumes and open interest as the 30 December 2025 expiry approaches. This activity reflects a cautious stance among investors amid recent price movements and sector dynamics.

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-18 09:21:17

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the Indian equity market’s core. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are compelled to hold shares of Sun Pharma, thereby creating a steady demand irrespective of short-term market fluctuations.

Moreover, inclusion in the benchmark index often leads to increased scrutiny and expectations regarding corporate governance, financial transparency, and consistent performance. For Sun Pharmace...

Sun Pharmaceutical Industries: Analytical Perspective Shift Amid Mixed Technical and Financial Signals

2025-12-17 08:22:15

Sun Pharmaceutical Industries has experienced a revision in its market assessment, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article examines the factors influencing the recent analytical perspective shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics

2025-12-16 09:21:01

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.

Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark...

Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment

2025-12-15 08:04:43

Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory.

Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors

2025-12-12 08:11:55

Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

Sun Pharmaceutical Industries Shows Mixed Technical Momentum Amid Market Fluctuations

2025-12-12 08:08:57

Sun Pharmaceutical Industries has exhibited a nuanced shift in its technical momentum, reflecting a blend of bullish signals on shorter timeframes and more cautious indications over longer periods. The stock’s recent price movements and technical indicators suggest a complex market assessment, with investors weighing near-term optimism against broader market trends.